Importantly, EBI2 expression was further decreased in cMos from IFN‐positive SLE patients (p < 0.0001), in contrast to normal expression in IFN‐negative SLE patients (p = 0.1663) (Figure 2A). This evidence concerns the gene GPR183 and systemic lupus erythematosus.